Varex Imaging Conference Call Summary Company Overview - **Company**: Varex Imaging - **Business Segments**: - Medical Imaging: Approximately 70% of revenues - Industrial Imaging: Approximately 30% of revenues - **Products**: X-ray tubes, X-ray detectors, associated software, and other components - **Key Customers**: Major medical imaging OEMs including GE, Siemens, Philips, Canon, and Hologic [3][4] Core Business Insights - **Tariff Mitigation**: - Successfully passed increased tariff costs to customers since April 2022 - Increased local manufacturing in China and Europe to mitigate tariffs - Recent Supreme Court ruling has reduced tariff rates, expected to positively impact P&L in 4-6 months [5][6][7][8][9] - **Market Environment**: - Stable demand in medical imaging with hospital capital expenditure (CapEx) remaining a top priority - Historical resilience during economic downturns, with stable to slight growth observed [10][11][12] - Channel inventory issues have been resolved, leading to improved procurement from China [13] - **Customer Engagement**: - Increased collaboration with major customers on new system developments, showing positive engagement and excitement [14] Industry Trends - **Transition from Analog to Digital**: - Complete in developed markets (U.S., Western Europe, Japan) but ongoing in regions like South Asia and certain Latin American countries [15][16] - **New Manufacturing in India**: - Two factories being established for radiographic products to regain market share in price-sensitive segments - First factory for detectors is operational but not yet at full capacity; second factory expected to be completed by end of 2023 [17][18][19][21] Industrial Segment Performance - **Cargo Inspection Systems**: - Strong sales of $55 million in FY25, with expectations for continued demand in FY26 driven by increased border security and tariff compliance needs [22][23][24][25] - **Service Revenue**: - Service revenue from cargo systems expected to be accretive to margins, typically starting after a warranty period of about 18 months [26][27] Technological Advancements - **Photon Counting Technology**: - Offers advantages such as high-speed imaging (10,000 frames per second) and significant dosage reduction (60-70% less) in medical applications - Expected to enhance image quality and provide material discrimination capabilities [28][29][30][31][32] - Anticipated market introduction in early 2027, with ongoing collaborations with customers [33][35] Financial Health - **Debt Refinancing**: - Total debt reduced to $350 million with a new coupon rate of approximately 6%, down from 7.875% - $18 million of debt paid down as part of refinancing, allowing for flexibility in future cash flow management [38][39][40] Future Outlook - **Exciting Developments**: - Anticipated growth from photon counting, cargo inspection, and Indian manufacturing initiatives - Focus on improving operating leverage and EBITDA margins as new products ramp up [44] - **Concerns**: - Ongoing volatility and uncertainty in the policy environment, which poses challenges for strategic planning [45]